Literature DB >> 20307087

Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells.

Feng Li1, Suresh Awale, Yasuhiro Tezuka, Hiroyasu Esumi, Shigetoshi Kadota.   

Abstract

Three new flavonoids, (2R,3R)-3,5-dihydroxy-7-methoxyflavanone 3-(2-methyl)butyrate (1), (7''R)-8-[1-(4'-hydroxy-3'-methoxyphenyl)prop-2-en-1-yl]chrysin (2), and (7''R)-8-[1-(4'-hydroxy-3'-methoxyphenyl)prop-2-en-1-yl]galangin (3), together with 41 known compounds (4-44) were isolated from a methanolic extract of Mexican propolis. Compounds 2 and 3 are unique natural flavones containing a 1-phenylallyl moiety. The in vitro preferential cytotoxicity of all the isolates was evaluated against a PANC-1 human pancreatic cell line. Compound 3 displayed the most potent preferential cytotoxicity (PC(50) 4.6 microM) in the nutrient-deprived medium (NDM) and triggered apoptosis-like morphological changes in PANC-1 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307087     DOI: 10.1021/np900772m

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  22 in total

1.  Molecular structure and anti-proliferative effect of galangin in HCT-116 cells: In vitro study.

Authors:  Ghassan Mohammad Sulaiman
Journal:  Food Sci Biotechnol       Date:  2016-02-29       Impact factor: 2.391

2.  Flavonoids from Heliotropium subulatum exudate and their evaluation for antioxidant, antineoplastic and cytotoxic activities II.

Authors:  Bharat Singh; Pooran M Sahu; Ram A Sharma
Journal:  Cytotechnology       Date:  2016-11-30       Impact factor: 2.058

Review 3.  Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.

Authors:  Hiroshi Kitamura
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

4.  Galangin, a dietary flavonoid, improves antioxidant status and reduces hyperglycemia-mediated oxidative stress in streptozotocin-induced diabetic rats.

Authors:  Amal A Aloud; Chinnadurai Veeramani; Chandramohan Govindasamy; Mohammed A Alsaif; Ahmed S El Newehy; Khalid S Al-Numair
Journal:  Redox Rep       Date:  2016-12-28       Impact factor: 4.412

Review 5.  Propolis: An update on its chemistry and pharmacological applications.

Authors:  Rajib Hossain; Cristina Quispe; Rasel Ahmed Khan; Abu Saim Mohammad Saikat; Pranta Ray; Damira Ongalbek; Balakyz Yeskaliyeva; Divya Jain; Antonella Smeriglio; Domenico Trombetta; Roghayeh Kiani; Farzad Kobarfard; Naheed Mojgani; Parvaneh Saffarian; Seyed Abdulmajid Ayatollahi; Chandan Sarkar; Mohammad Torequl Islam; Dılhun Keriman; Arserim Uçar; Miquel Martorell; Antoni Sureda; Gianfranco Pintus; Monica Butnariu; Javad Sharifi-Rad; William C Cho
Journal:  Chin Med       Date:  2022-08-26       Impact factor: 4.546

6.  Iridium-Catalyzed Enantioselective Allylic Substitution of Enol Silanes from Vinylogous Esters and Amides.

Authors:  Ming Chen; John F Hartwig
Journal:  J Am Chem Soc       Date:  2015-10-23       Impact factor: 15.419

7.  Antifungal and antibacterial metabolites from a French poplar type propolis.

Authors:  Séverine Boisard; Anne-Marie Le Ray; Anne Landreau; Marie Kempf; Viviane Cassisa; Catherine Flurin; Pascal Richomme
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-22       Impact factor: 2.629

8.  Development and extraction optimization of baicalein and pinostrobin from Scutellaria violacea through response surface methodology.

Authors:  Shankar Subramaniam; Ravikumar Raju; Anbumathi Palanisamy; Aravind Sivasubramanian
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

9.  Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway.

Authors:  Lingchen Tao; Xi Chen; Yufei Zheng; Yuqi Wu; Xiasen Jiang; Mengmeng You; Shanshan Li; Fuliang Hu
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

10.  Comparative chemistry of propolis from eight brazilian localities.

Authors:  A A Righi; G Negri; A Salatino
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.